• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 28, 2024

    3/28/24 5:24:44 AM ET
    $ACHV
    $ACNT
    $AFMD
    $AONC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Steel/Iron Ore
    Industrials
    Get the next $ACHV alert in real time by email

    Companies Reporting Before The Bell

    • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

    • Shimmick (NASDAQ:SHIM) is estimated to report quarterly loss at $0.20 per share on revenue of $158.50 million.

    • MSC Industrial Direct Co (NYSE:MSM) is estimated to report quarterly earnings at $1.16 per share on revenue of $946.55 million.

    • Walgreens Boots Alliance (NASDAQ:WBA) is likely to report quarterly earnings at $0.75 per share on revenue of $33.03 billion.

    • Data Storage (NASDAQ:DTST) is projected to report earnings for its fourth quarter.

    • Affimed (NASDAQ:AFMD) is likely to report quarterly loss at $1.68 per share on revenue of $1.71 million.

    • Atour Lifestyle Holdings (NASDAQ:ATAT) is expected to report quarterly earnings at $0.19 per share on revenue of $168.26 million.

    • CNFinance Hldgs (NYSE:CNF) is likely to report quarterly earnings at $0.01 per share on revenue of $65.41 million.

    • BRP (NASDAQ:DOOO) is estimated to report quarterly earnings at $1.92 per share on revenue of $2.05 billion.

    • OptimizeRx (NASDAQ:OPRX) is estimated to report quarterly earnings at $0.26 per share on revenue of $26.47 million.

    • Azul (NYSE:AZUL) is likely to report quarterly earnings at $0.14 per share on revenue of $985.30 million.

    • Imunon (NASDAQ:IMNN) is projected to report earnings for its fourth quarter.

    • Iterum Therapeutics (NASDAQ:ITRM) is expected to report earnings for its fourth quarter.

    • DarioHealth (NASDAQ:DRIO) is projected to report quarterly loss at $0.54 per share on revenue of $3.57 million.

    • Cheche Group (NASDAQ:CCG) is expected to report earnings for its fourth quarter.

    • Telesat (NASDAQ:TSAT) is projected to report earnings for its fourth quarter.

    • Jiayin Gr (NASDAQ:JFIN) is projected to report earnings for its fourth quarter.

    • IM Cannabis (NASDAQ:IMCC) is estimated to report quarterly loss at $0.17 per share on revenue of $10.45 million.

    • Smart Share Glb (NASDAQ:EM) is expected to report earnings for its fourth quarter.

    • 36KR Holdings (NASDAQ:KRKR) is projected to report earnings for its fourth quarter.

    • 22nd Century Group (NASDAQ:XXII) is estimated to report quarterly loss at $0.55 per share on revenue of $17.10 million.

    • China Automotive Systems (NASDAQ:CAAS) is estimated to report earnings for its fourth quarter.

    • REX American Resources (NYSE:REX) is expected to report quarterly earnings at $0.68 per share on revenue of $190.26 million.

    • D-Wave Quantum (NYSE:QBTS) is projected to report quarterly loss at $0.10 per share on revenue of $4.73 million.

    • Hut 8 (NASDAQ:HUT) is expected to report quarterly loss at $0.25 per share on revenue of $23.66 million.

    • American Oncology Network (NASDAQ:AONC) is estimated to report earnings for its fourth quarter.

    • Gold Royalty (AMEX:GROY) is estimated to report quarterly loss at $0.01 per share on revenue of $1.90 million.

    • Better Home & Finance (NASDAQ:BETR) is projected to report earnings for its fourth quarter.

    • BOS Better Online Solns (NASDAQ:BOSC) is projected to report earnings for its fourth quarter.

    Companies Reporting After The Bell

    • INmune Bio (NASDAQ:INMB) is estimated to report quarterly loss at $0.44 per share on revenue of $40 thousand.

    • Dolphin Entertainment (NASDAQ:DLPN) is likely to report quarterly earnings at $0.00 per share on revenue of $11.10 million.

    • Ascent Industries (NASDAQ:ACNT) is expected to report quarterly loss at $0.08 per share on revenue of $63.50 million.

    • Kodiak Sciences (NASDAQ:KOD) is expected to report earnings for its fourth quarter.

    • Pineapple Energy (NASDAQ:PEGY) is estimated to report quarterly earnings at $0.00 per share on revenue of $20.40 million.

    • Oxford Industries (NYSE:OXM) is projected to report quarterly earnings at $1.95 per share on revenue of $408.18 million.

    • Naas Technology (NASDAQ:NAAS) is estimated to report earnings for its fourth quarter.

    • Danimer Scientific (NYSE:DNMR) is projected to report quarterly loss at $0.38 per share on revenue of $11.33 million.

    • Dare Bioscience (NASDAQ:DARE) is expected to report quarterly loss at $0.10 per share on revenue of $1.79 million.

    • Intellinetics (AMEX:INLX) is estimated to report quarterly earnings at $0.04 per share on revenue of $4.10 million.

    • Shapeways Holdings (NASDAQ:SHPW) is expected to report quarterly loss at $0.95 per share on revenue of $9.25 million.

    • NRX Pharmaceuticals (NASDAQ:NRXP) is expected to report earnings for its fourth quarter.

    • CVD Equipment (NASDAQ:CVV) is projected to report earnings for its fourth quarter.

    • Nuvve Holding (NASDAQ:NVVE) is expected to report quarterly loss at $5.60 per share on revenue of $3.00 million.

    • NexGel (NASDAQ:NXGL) is projected to report quarterly loss at $0.11 per share on revenue of $1.38 million.

    • ENDRA Life Sciences (NASDAQ:NDRA) is expected to report earnings for its fourth quarter.

    • Zevra Therapeutics (NASDAQ:ZVRA) is estimated to report quarterly loss at $0.27 per share on revenue of $11.74 million.

    • American Res (NASDAQ:AREC) is projected to report quarterly loss at $0.04 per share on revenue of $2.20 million.

    • Vicinity Motor (NASDAQ:VEV) is estimated to report quarterly loss at $0.06 per share on revenue of $12.62 million.

    • Helius Medical Tech (NASDAQ:HSDT) is likely to report quarterly loss at $3.77 per share on revenue of $250 thousand.

    • Surf Air Mobility (NYSE:SRFM) is likely to report quarterly loss at $0.28 per share on revenue of $25.69 million.

    • Emeren Group (NYSE:SOL) is likely to report quarterly earnings at $0.00 per share on revenue of $44.98 million.

    • P3 Health Partners (NASDAQ:PIII) is expected to report quarterly loss at $0.11 per share on revenue of $302.97 million.

    • Energous (NASDAQ:WATT) is estimated to report quarterly loss at $0.85 per share on revenue of $200 thousand.

    • Dyadic International (NASDAQ:DYAI) is likely to report quarterly loss at $0.06 per share on revenue of $800 thousand.

    • Semtech (NASDAQ:SMTC) is projected to report quarterly loss at $0.03 per share on revenue of $196.46 million.

    • Torrid Holdings (NYSE:CURV) is likely to report quarterly loss at $0.08 per share on revenue of $274.83 million.

    • Pulse Biosciences (NASDAQ:PLSE) is likely to report earnings for its fourth quarter.

    • Arcadia Biosciences (NASDAQ:RKDA) is projected to report quarterly loss at $2.58 per share on revenue of $1.75 million.

    • Achieve Life Sciences (NASDAQ:ACHV) is projected to report earnings for its fourth quarter.

    • Sharecare (NASDAQ:SHCR) is expected to report quarterly loss at $0.06 per share on revenue of $114.99 million.

    • Expion360 (NASDAQ:XPON) is projected to report quarterly loss at $0.28 per share on revenue of $980 thousand.

    • Cepton (NASDAQ:CPTN) is expected to report quarterly loss at $0.74 per share on revenue of $2.46 million.

    • Vuzix (NASDAQ:VUZI) is estimated to report quarterly loss at $0.15 per share on revenue of $2.14 million.

    • Aspira Womens Health (NASDAQ:AWH) is estimated to report quarterly loss at $0.45 per share on revenue of $2.54 million.

    • Forian (NASDAQ:FORA) is estimated to report quarterly loss at $0.03 per share on revenue of $5.56 million.

    • Accelerate Diagnostics (NASDAQ:AXDX) is estimated to report quarterly loss at $0.62 per share on revenue of $3.45 million.

    • Wrap Technologies (NASDAQ:WRAP) is likely to report earnings for its fourth quarter.

    • Planet Labs (NYSE:PL) is projected to report quarterly loss at $0.06 per share on revenue of $58.19 million.

    • Leafly Holdings (NASDAQ:LFLY) is likely to report quarterly loss at $1.45 per share on revenue of $9.49 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACHV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHV
    $ACNT
    $AFMD
    $AONC

    CompanyDatePrice TargetRatingAnalyst
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    MSC Industrial Direct Company Inc.
    $MSM
    2/6/2026$95.00Overweight → Neutral
    Analyst
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Gold Royalty Corp.
    $GROY
    1/22/2026Buy → Hold
    Canaccord Genuity
    Oxford Industries Inc.
    $OXM
    1/13/2026$35.00 → $40.00Market Perform
    Telsey Advisory Group
    Shimmick Corporation
    $SHIM
    1/5/2026$6.00Hold → Buy
    Craig Hallum
    Atour Lifestyle Holdings Limited
    $ATAT
    1/2/2026$49.00Outperform
    CLSA
    More analyst ratings

    $ACHV
    $ACNT
    $AFMD
    $AONC
    SEC Filings

    View All

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/27/26 5:26:13 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    INmune Bio Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Inmune Bio, Inc. (0001711754) (Filer)

    2/27/26 9:14:34 AM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 10-K filed by D-Wave Quantum Inc.

    10-K - D-Wave Quantum Inc. (0001907982) (Filer)

    2/26/26 4:13:29 PM ET
    $QBTS
    EDP Services
    Technology

    $ACHV
    $ACNT
    $AFMD
    $AONC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for XACIATO issued to DARE BIOSCIENCE INC

    Submission status for DARE BIOSCIENCE INC's drug XACIATO (ORIG-1) with active ingredient CLINDAMYCIN PHOSPHATE has changed to 'Approval' on 12/07/2021. Application Category: NDA, Application Number: 215650, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/7/21 12:35:25 PM ET
    $DARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vuzix Schedules Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results and Business Update

    ROCHESTER, N.Y., Feb. 27, 2026 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, is pleased to announce that the Company will host a conference call regarding its fourth quarter and full year 2025 operating results on Thursday, March 12, 2026 at 4:30 PM Eastern Time (ET). To join the live conference call, please dial 877-709-8150 (U.S. and Canadian callers) or 201-689-8354 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the schedul

    2/27/26 3:00:00 PM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Shimmick Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2025

    IRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Shimmick Corporation ("Shimmick") (NASDAQ:SHIM), a national leader in complex infrastructure solutions, today announced that the company will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2025. Shimmick will also host a video webcast conference call to discuss those results at 4:30 p.m. Eastern Time on the same day. The conference call will be live-streamed via the Company's Investor Relations website (https://investors.shimmick.com/). A copy of the earnings call presentation will also be posted to our website. A replay of the video webcast will be available through the same link

    2/26/26 4:05:00 PM ET
    $SHIM
    Military/Government/Technical
    Industrials

    Surf Air Mobility to Announce Fourth Quarter and Year-end 2025 Financial Results on March 12, 2026

    Surf Air Mobility Inc. (NYSE:SRFM) a leading air mobility platform, today announced that it will release its fourth quarter and year-end 2025 financial results after market close on Thursday, March 12, 2026, and will host a webcast at 5:00 pm ET the same day. Interested parties can register in advance to listen to the webcast here or can find a link on the ‘Events & Presentations' section of our investor relations website. Alternatively, listeners may dial into the call as follows: North America - Toll-Free (800) 715-9871 International (Toll) - (646) 307-1963 Conference ID: 4775356 About Surf Air Mobility Surf Air Mobility is a Los Angeles-based air mobility platform. With its AI-en

    2/26/26 4:05:00 PM ET
    $SRFM
    Transportation Services
    Consumer Discretionary

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,950 worth of shares (3,000 units at $1.65), increasing direct ownership by 0.68% to 440,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/24/26 7:08:09 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,851 worth of shares (3,300 units at $1.47), increasing direct ownership by 0.76% to 437,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/17/26 5:36:47 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,920 worth of shares (3,000 units at $1.64), increasing direct ownership by 0.69% to 434,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/11/26 4:38:15 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on D-Wave Quantum

    TD Cowen initiated coverage of D-Wave Quantum with a rating of Buy

    2/12/26 7:24:12 AM ET
    $QBTS
    EDP Services
    Technology

    MSC Industrial downgraded by Analyst with a new price target

    Analyst downgraded MSC Industrial from Overweight to Neutral and set a new price target of $95.00

    2/6/26 8:09:59 AM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    H.C. Wainwright resumed coverage on Hut 8 Mining with a new price target

    H.C. Wainwright resumed coverage of Hut 8 Mining with a rating of Buy and set a new price target of $80.00

    2/2/26 6:51:37 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,950 worth of shares (3,000 units at $1.65), increasing direct ownership by 0.68% to 440,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/24/26 7:08:09 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    EVP, Chief Legal Officer & GC Nguyen Diane was granted 28,068 shares, increasing direct ownership by 5% to 566,206 units (SEC Form 4)

    4 - D-Wave Quantum Inc. (0001907982) (Issuer)

    2/24/26 5:12:11 PM ET
    $QBTS
    EDP Services
    Technology

    Chief Commercial Officer Danahy Kevin Patrick exercised 5,000 shares at a strike of $1.53 and sold $118,200 worth of shares (5,000 units at $23.64) (SEC Form 4)

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/23/26 8:55:39 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Leadership Updates

    Live Leadership Updates

    View All

    Transpire Bio Strengthens its Leadership Team with Appointment of LaDuane Clifton as Chief Financial Officer

    SUNRISE, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced the appointment of R. LaDuane Clifton as Chief Financial Officer (CFO). "As Transpire Bio continues to progress from a clinical-stage to commercial-stage biopharmaceutical company, we are aligning our leadership structure to support the next phase of our growth," said Dr. Xian-Ming Zeng, Chief Executive Officer of Transpire Bio. "We are thrilled to welcome Mr. Clifton as Chief Financial Officer. He brings extensive public company, global finance, and operations leadership

    2/24/26 3:42:26 PM ET
    $ZVRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Intellinetics, Inc. Appoints Alison Forsythe as President and Chief Executive Officer

    Proven Technology Executive to Lead Intellinetics Into Its Next Phase of Growth Intellinetics, Inc. (NYSE:INLX), a digital transformation solutions provider, today announced the appointment of Alison Forsythe as President and Chief Executive Officer, effective February 17, 2026. Ms. Forsythe is a seasoned SaaS and enterprise software executive with more than two decades of experience leading technology organizations through periods of growth, transformation, and scale. She is widely recognized for strengthening execution, aligning go-to-market strategies and building scalable software businesses that deliver sustained value for customers, partners, and shareholders. Mike Taglich, Chai

    2/17/26 8:00:00 AM ET
    $INLX
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Financials

    Live finance-specific insights

    View All

    Vuzix Schedules Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results and Business Update

    ROCHESTER, N.Y., Feb. 27, 2026 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, is pleased to announce that the Company will host a conference call regarding its fourth quarter and full year 2025 operating results on Thursday, March 12, 2026 at 4:30 PM Eastern Time (ET). To join the live conference call, please dial 877-709-8150 (U.S. and Canadian callers) or 201-689-8354 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the schedul

    2/27/26 3:00:00 PM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Shimmick Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2025

    IRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Shimmick Corporation ("Shimmick") (NASDAQ:SHIM), a national leader in complex infrastructure solutions, today announced that the company will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2025. Shimmick will also host a video webcast conference call to discuss those results at 4:30 p.m. Eastern Time on the same day. The conference call will be live-streamed via the Company's Investor Relations website (https://investors.shimmick.com/). A copy of the earnings call presentation will also be posted to our website. A replay of the video webcast will be available through the same link

    2/26/26 4:05:00 PM ET
    $SHIM
    Military/Government/Technical
    Industrials

    Surf Air Mobility to Announce Fourth Quarter and Year-end 2025 Financial Results on March 12, 2026

    Surf Air Mobility Inc. (NYSE:SRFM) a leading air mobility platform, today announced that it will release its fourth quarter and year-end 2025 financial results after market close on Thursday, March 12, 2026, and will host a webcast at 5:00 pm ET the same day. Interested parties can register in advance to listen to the webcast here or can find a link on the ‘Events & Presentations' section of our investor relations website. Alternatively, listeners may dial into the call as follows: North America - Toll-Free (800) 715-9871 International (Toll) - (646) 307-1963 Conference ID: 4775356 About Surf Air Mobility Surf Air Mobility is a Los Angeles-based air mobility platform. With its AI-en

    2/26/26 4:05:00 PM ET
    $SRFM
    Transportation Services
    Consumer Discretionary

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Better Home & Finance Holding Company

    SC 13D/A - Better Home & Finance Holding Co (0001835856) (Subject)

    12/17/24 8:40:06 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care